Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression. [electronic resource] by
- Seymour, John F
- Marcus, Robert
- Davies, Andrew
- Gallop-Evans, Eve
- Grigg, Andrew
- Haynes, Andrew
- Herold, Michael
- Illmer, Thomas
- Nilsson-Ehle, Herman
- Sökler, Martin
- Dünzinger, Ulrich
- Nielsen, Tina
- Launonen, Aino
- Hiddemann, Wolfgang
Publication details: Haematologica May 2020
In:
Haematologica vol. 105
Availability: No items available.
|
|
9.
|
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression. [electronic resource] by
- Seymour, John F
- Marcus, Robert
- Davies, Andrew
- Gallop-Evans, Eve
- Grigg, Andrew
- Haynes, Andrew
- Herold, Michael
- Illmer, Thomas
- Nilsson-Ehle, Herman
- Sökler, Martin
- Dünzinger, Ulrich
- Nielsen, Tina
- Launonen, Aino
- Hiddemann, Wolfgang
Producer: 20200518
In:
Haematologica vol. 104
Availability: No items available.
|
|
10.
|
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. [electronic resource] by
- Böll, Boris
- Plütschow, Annette
- Bürkle, Carolin
- Atta, Johannes
- Pfreundschuh, Michael
- Feuring-Buske, Michaela
- Vogelhuber, Martin
- Sökler, Martin
- Eichenauer, Dennis A
- Thielen, Indra
- von Tresckow, Bastian
- Fuchs, Michael
- Engert, Andreas
- Borchmann, Peter
Producer: 20200219
In:
British journal of haematology vol. 185
Availability: No items available.
|
|
11.
|
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. [electronic resource] by
- Eichenauer, Dennis A
- Plütschow, Annette
- Kreissl, Stefanie
- Sökler, Martin
- Hellmuth, Johannes C
- Meissner, Julia
- Mathas, Stephan
- Topp, Max S
- Behringer, Karolin
- Klapper, Wolfram
- Kuhnert, Georg
- Dietlein, Markus
- Kobe, Carsten
- Fuchs, Michael
- Diehl, Volker
- Engert, Andreas
- Borchmann, Peter
Producer: 20171215
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
12.
|
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. [electronic resource] by
- Engert, Andreas
- Josting, Andreas
- Haverkamp, Heinz
- Villalobos, Matthias
- Lohri, Andreas
- Sökler, Martin
- Zijlstra, Josée
- Sturm, Isrid
- Topp, Max S
- Rank, Andreas
- Zenz, Thorsten
- Vogelhuber, Martin
- Nogova, Lucia
- Borchmann, Peter
- Fuchs, Michael
- Flechtner, Hans-Henning
- Diehl, Volker
Producer: 20100513
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
13.
|
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. [electronic resource] by
- Bröckelmann, Paul J
- Goergen, Helen
- Keller, Ulrich
- Meissner, Julia
- Ordemann, Rainer
- Halbsguth, Teresa V
- Sasse, Stephanie
- Sökler, Martin
- Kerkhoff, Andrea
- Mathas, Stephan
- Hüttmann, Andreas
- Bormann, Matthias
- Zimmermann, Andreas
- Mettler, Jasmin
- Fuchs, Michael
- von Tresckow, Bastian
- Baues, Christian
- Rosenwald, Andreas
- Klapper, Wolfram
- Kobe, Carsten
- Borchmann, Peter
- Engert, Andreas
Producer: 20210122
In:
JAMA oncology vol. 6
Availability: No items available.
|
|
14.
|
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. [electronic resource] by
- Engert, Andreas
- Plütschow, Annette
- Eich, Hans Theodor
- Lohri, Andreas
- Dörken, Bernd
- Borchmann, Peter
- Berger, Bernhard
- Greil, Richard
- Willborn, Kay C
- Wilhelm, Martin
- Debus, Jürgen
- Eble, Michael J
- Sökler, Martin
- Ho, Antony
- Rank, Andreas
- Ganser, Arnold
- Trümper, Lorenz
- Bokemeyer, Carsten
- Kirchner, Hartmut
- Schubert, Jörg
- Král, Zdenek
- Fuchs, Michael
- Müller-Hermelink, Hans-Konrad
- Müller, Rolf-Peter
- Diehl, Volker
Producer: 20100914
In:
The New England journal of medicine vol. 363
Availability: No items available.
|
|
15.
|
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. [electronic resource] by
- Eichhorst, Barbara
- Fink, Anna-Maria
- Bahlo, Jasmin
- Busch, Raymonde
- Kovacs, Gabor
- Maurer, Christian
- Lange, Elisabeth
- Köppler, Hubert
- Kiehl, Michael
- Sökler, Martin
- Schlag, Rudolf
- Vehling-Kaiser, Ursula
- Köchling, Georg
- Plöger, Christoph
- Gregor, Michael
- Plesner, Torben
- Trneny, Marek
- Fischer, Kirsten
- Döhner, Harmut
- Kneba, Michael
- Wendtner, Clemens-Martin
- Klapper, Wolfram
- Kreuzer, Karl-Anton
- Stilgenbauer, Stephan
- Böttcher, Sebastian
- Hallek, Michael
Producer: 20170605
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|
|
16.
|
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG). [electronic resource] by
- Kutsch, Nadine
- Bahlo, Jasmin
- Robrecht, Sandra
- Franklin, Jeremy
- Zhang, Can
- Maurer, Christian
- De Silva, Nisha
- Lange, Elisabeth
- Weide, Rudolf
- Kiehl, Michael G
- Sökler, Martin
- Schlag, Rudolf
- Vehling-Kaiser, Ursula
- Köchling, Georg
- Plöger, Christoph
- Gregor, Michael
- Plesner, Torben
- Herling, Marco
- Fischer, Kirsten
- Döhner, Hartmut
- Kneba, Michael
- Wendtner, Clemens-Martin
- Klapper, Wolfram
- Kreuzer, Karl-Anton
- Böttcher, Sebastian
- Stilgenbauer, Stephan
- Fink, Anna Maria
- Hallek, Michael
- Eichhorst, Barbara
Publication details: HemaSphere Feb 2020
In:
HemaSphere vol. 4
Availability: No items available.
|